- Home
- ZDGE vs CASI Comparison
ZDGE vs CASI Comparison
Compare ZDGE & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- CASI
- Stock Information
- Founded
- ZDGE 2008
- CASI 1991
- Country
- ZDGE United States
- CASI China
- Employees
- ZDGE N/A
- CASI N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- CASI Health Care
- Exchange
- ZDGE Nasdaq
- CASI Nasdaq
- Market Cap
- ZDGE 40.3M
- CASI 33.4M
- IPO Year
- ZDGE N/A
- CASI 1996
- Fundamental
- Price
- ZDGE $2.31
- CASI $2.10
- Analyst Decision
- ZDGE
- CASI Strong Buy
- Analyst Count
- ZDGE 0
- CASI 1
- Target Price
- ZDGE N/A
- CASI $6.00
- AVG Volume (30 Days)
- ZDGE 32.7K
- CASI 8.5K
- Earning Date
- ZDGE 03-12-2025
- CASI 03-31-2025
- Dividend Yield
- ZDGE N/A
- CASI N/A
- EPS Growth
- ZDGE N/A
- CASI N/A
- EPS
- ZDGE N/A
- CASI N/A
- Revenue
- ZDGE $29,412,000.00
- CASI $22,055,000.00
- Revenue This Year
- ZDGE $0.34
- CASI N/A
- Revenue Next Year
- ZDGE $6.35
- CASI $134.79
- P/E Ratio
- ZDGE N/A
- CASI N/A
- Revenue Growth
- ZDGE 4.26
- CASI N/A
- 52 Week Low
- ZDGE $1.93
- CASI $2.04
- 52 Week High
- ZDGE $4.38
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- ZDGE 42.61
- CASI 45.16
- Support Level
- ZDGE $2.26
- CASI $2.10
- Resistance Level
- ZDGE $2.49
- CASI $2.52
- Average True Range (ATR)
- ZDGE 0.15
- CASI 0.20
- MACD
- ZDGE 0.02
- CASI 0.01
- Stochastic Oscillator
- ZDGE 57.69
- CASI 27.42
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.